GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,440 | -58,013 | -39,991 | -34,538 | -29,677 |
| Accounts payable and accrued liabilities | -838 | 7,077 | 537 | -611 | N/A |
| Other Working Capital | -1,100 | 8,660 | 1,505 | -309 | 1,215 |
| Other Operating Activity | 2,163 | 26,670 | 26,048 | 27,486 | 24,778 |
| Operating Cash Flow | $-5,215 | $-15,606 | $-11,901 | $-7,972 | $-3,684 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,533 | N/A | -26,031 | N/A | N/A |
| Purchase Of Investment | N/A | -23,040 | N/A | N/A | N/A |
| Investing Cash Flow | $3,533 | $-23,040 | $-26,031 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,205 | 1,205 | 1,205 | 1,205 |
| Common Stock Issued | N/A | 41,112 | 41,112 | 40,975 | 24,737 |
| Financing Cash Flow | $N/A | $42,317 | $42,317 | $42,180 | $25,942 |
| Beginning Cash Position | 8,968 | 5,297 | 5,297 | 5,297 | 5,297 |
| End Cash Position | 7,286 | 8,968 | 9,682 | 39,505 | 27,555 |
| Net Cash Flow | $-1,682 | $3,671 | $4,385 | $34,208 | $22,258 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,215 | -15,606 | -11,901 | -7,972 | -3,684 |
| Free Cash Flow | -5,215 | -15,606 | -11,901 | -7,972 | -3,684 |